1.Assessment of Olfactory Function after Endoscopic Sinus Surgery in Chronic Rhinosinusitis Patients and Clinical Validity of Cross-Cultrual Smell Identification Test.
Chan RHYOO ; Min Kyo JUNG ; Young Ha JU ; Jin Ho YUM ; Jae Hyun SEO ; Mun Suk KIM
Korean Journal of Otolaryngology - Head and Neck Surgery 2001;44(10):1053-1059
BACKGROUND AND OBJECTIVES: Endoscopic sinus surgery (ESS) improves olfactory dysfunction due to chronic rhinosinusitis. Cross-Cultural Smell Identification test (CC-SIT) is known to be one of the useful methods to assess the olfactory dysfunction. We assessed the influence of ESS on olfactory function by using symptom scores and CC-SIT, and determined the clinical validity of CC-SIT. MATERIALS AND METHODS: 151 patients with chronic rhinosinusitis who had received ESS were evaluated. Prior to and three months following the surgery, each patient was requested to mark a 5-point scale ranging from normosmia to anosmia. Preoperative and postoperative CC-SITs were performed for 20 patients who complained of olfactory dysfunction. To evaluate the clinical validity of CC-SIT, we assessed the correlations between CC-SIT scores, symptom scores and CT scores using the Lund-Mackay CT scoring system. RESULTS: There were a significant decrease in the symptom scores and an increase in the CC-SIT scores after ESS. However, normosmia was achieved in only 38.5% (25/65) of the patients determined by symptom scores and 23.5% (4/17) by CC-SITs. There were significant correlations between CC-SIT scores, symptom scores and CT scores (r=-0.416, r=-0.357, r=0.510, p<0.05). CONCLUSION: Although the average postoperative olfactory ability after ESS was in the hyposmic range, ESS could improve the olfactory ability in patients with chronic rhinosinusitis. The 5-point scale and the CC-SIT scores reflected well the severity of olfactory dysfunction in patients with chronic rhinosinusitis, and therefore, we recommend them as convenient and practical tools to assess olfactory ability before and after ESS.
Humans
;
Olfaction Disorders
;
Smell*
2.A Case of Olfactory Groove Meningioma Presenting Anosmia.
Seong Phill MOON ; Joo Hyun JUNG ; Seon Tae KIM ; Il Gyu KANG
Korean Journal of Otolaryngology - Head and Neck Surgery 2011;54(6):431-434
The common causes of anosmia include sinonasal disorder, post-upper respiratory infection, trauma and chemicals. Intracranial tumor also frequently cause anosmia, so it is not easy to diagnose an intracranial tumor in patients who present with no definite related symptoms other than anosmia. Therefore, otolaryngologists should focus their attention on these disorders when they see patients with anosmia. We have experienced a case of olfactory groove menigioma presenting with only anosmia. We herein report this case with a brief review of the literature.
Humans
;
Meningioma
;
Olfaction Disorders
4.MR Findings of Kallmann Syndrome.
Sung Mi KIM ; Jin Ok CHOI ; Kang Soo LEE ; See Sung CHOI
Journal of the Korean Radiological Society 2000;42(4):601-604
Kallman syndrome is characterised by hypogonadotrophic hypogonadism and anosmia. T1 weighted MR coronal images show the bilateral absence or hypoplasia of olfactory bulbs, tracts, and sulci. We report the MR findings of Kallmann syndrome and revew the literature.
Hypogonadism
;
Kallmann Syndrome*
;
Olfaction Disorders
;
Olfactory Bulb
5.The Efficacy of Stellate Ganglion Block in Sensorineural Anosmia Patients Unresponsive to Steroid Therapy.
Ho Sik MOON ; Hae Jin LEE ; Choon Ho SUNG ; Su Jin LIM ; Jin Hwan CHOI
The Korean Journal of Pain 2007;20(2):154-157
BACKGROUND: Anosmia can be frustrating for both the patient and physician, with no clear treatment. We prospectively investigated the effects of stellate ganglion block (SGB) in anosmic patients who were unresponsive to conventional steroid therapy. METHODS: Thirteen patients with anosmia were treated with SGB. To evaluate the improvement in olfactory function, we evaluated both changes in subjective symptoms and the butanol threshold test. The number of SGB required for improvement in olfactory function was counted. RESULTS: Seven patients (54%) showed improvement of olfactory function with SGB. The average number of SGB for the first response was 7.4 +/- 5.9 times. CONCLUSIONS: These results suggest that SGB may be a good treatment modality for patients with anosmia unresponsive to steroid therapy.
Humans
;
Olfaction Disorders*
;
Prospective Studies
;
Stellate Ganglion*
8.Quantitative Evaluation of Efficacy of Systemic Steroid Therapy for the Patients with Olfactory Disturbance.
Yang Gi MIN ; Chul Hee LEE ; Tae Young KWON ; Chang Ho LEE ; Ja Bock YUN ; Kang Soo LEE
Korean Journal of Otolaryngology - Head and Neck Surgery 1998;41(1):37-41
OBJECTIVES: This study quantifies the efficacy of a short-term systemic steroid therapy in the patients with anosmia or hyposmia using the butanol threshold test (BTT) and the visual analogue scale (VAS). MATERIALS AND METHOD: Thirty patients with anosmia or hyposmia were included in this study from June 1996 through April 1997. The patients were divided into inflammatory and noninflammatory groups depending on the etiology. We evaluated the patients before and after the systemic steroid admi-nistration using both BTT and VAS. RESULTS: Overall improvements of olfactory function was observed upto 70% by BTT and 53% by VAS, and the therapeutic effect of steroid on olfactory malfunction was statistically significant (p=0.0001). Improvements in the olfaction was measured by BTT, which correlated strongly with the measurements by VAS with statistical significance (r=0.77578, p=0.0001). The inflammatory group showed better steroid response (83%) than the noninflammatory group (61%), but there was no statistical significance. CONCLUSION: The systemic steroid administration may be effective in the treatment of olfactory disturbance with a good correlation between BTT and VAS.
Evaluation Studies as Topic*
;
Humans
;
Olfaction Disorders
;
Smell
9.The Predictive Factors of Olfactory Changes after Endoscopic Sinus Surgery.
Journal of Rhinology 2018;25(2):63-68
Olfactory dysfunction is one of the most common complaints of patients with chronic rhinosinusitis. Patients who suffer from olfactory dysfunction report a negative effect on their overall quality of life. Chronic rhinosinusitis-related olfactory impairment is the most treatable form of olfactory disorder; however, outcomes after endoscopic sinus surgery (ESS) are challenging to predict. Previous studies have documented a wide range in overall improvement after ESS. The purpose of this study is to review the factors that predict changes in olfaction after ESS.
Humans
;
Olfaction Disorders
;
Quality of Life
;
Sinusitis
;
Smell
10.Clinical application and mechanism exploration on dysosmia treated with acupuncture and moxibustion.
Ming-Qi TU ; Han-Tong HU ; Ren-Jie HU ; Jian-Qiao FANG
Chinese Acupuncture & Moxibustion 2020;40(4):425-428
Dysosmia affects not only odour identification, but also memory, appetite, immunity and affection. Moreover, it suggests the occurrence of some diseases. The etiology of dysosmia is various and the treatment with western medicine is limited. In this paper, by analyzing the relevant research articles on olfactory disorders treatment with acupuncture and moxibustion, the clinical application of acupuncture and moxibustion, the thought of its diagnosis and treatment as well as relevant effect mechanism were explored. It is anticipated to provide the clinical physicians with the references to the treatment of dysosmia.
Acupuncture Therapy
;
Humans
;
Moxibustion
;
Olfaction Disorders
;
therapy